HomeCompareCLNY vs ARCC

CLNY vs ARCC: Dividend Comparison 2026

CLNY yields 116.94% · ARCC yields 10.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLNY wins by $498.5K in total portfolio value
10 years
CLNY
CLNY
● Live price
116.94%
Share price
$8.50
Annual div
$9.94
5Y div CAGR
-14.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$523.0K
Annual income
$55,958.00
Full CLNY calculator →
ARCC
Ares Capital Corporation
● Live price
10.65%
Share price
$18.02
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.14
Full ARCC calculator →

Portfolio growth — CLNY vs ARCC

📍 CLNY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLNYARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLNY + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLNY pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLNY
Annual income on $10K today (after 15% tax)
$9,940.00/yr
After 10yr DRIP, annual income (after tax)
$47,564.30/yr
ARCC
Annual income on $10K today (after 15% tax)
$905.66/yr
After 10yr DRIP, annual income (after tax)
$0.97/yr
At 15% tax rate, CLNY beats the other by $47,563.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLNY + ARCC for your $10,000?

CLNY: 50%ARCC: 50%
100% ARCC50/50100% CLNY
Portfolio after 10yr
$273.7K
Annual income
$27,979.57/yr
Blended yield
10.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

CLNY
Analyst Ratings
8
Buy
3
Hold
Consensus: Buy
Altman Z
-1.4
Piotroski
5/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+21.4% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLNY buys
0
ARCC buys
0
No recent congressional trades found for CLNY or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLNYARCC
Forward yield116.94%10.65%
Annual dividend / share$9.94$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-14.8%-50%
Portfolio after 10y$523.0K$24.5K
Annual income after 10y$55,958.00$1.14
Total dividends collected$396.1K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: CLNY vs ARCC ($10,000, DRIP)

YearCLNY PortfolioCLNY Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$20,663$9,963.39$11,373$532.74+$9.3KCLNY
2$38,503$16,393.23$12,608$279.46+$25.9KCLNY
3$65,521$24,322.81$13,809$142.90+$51.7KCLNY
4$103,065$32,957.60$15,042$72.20+$88.0KCLNY
5$151,560$41,280.24$16,341$36.27+$135.2KCLNY
6$210,505$48,335.99$17,732$18.18+$192.8KCLNY
7$278,697$53,457.01$19,231$9.10+$259.5KCLNY
8$354,561$56,354.79$20,851$4.55+$333.7KCLNY
9$436,468$57,087.98$22,605$2.28+$413.9KCLNY
10$522,979$55,958.00$24,504$1.14+$498.5KCLNY

CLNY vs ARCC: Complete Analysis 2026

CLNYStock

Colony Capital, Inc. (NYSE: CLNY) is a leading global investment firm with a heritage of identifying and capitalizing on key secular trends in real estate. The Company manages an approximately $47 billion portfolio of real assets on behalf of its shareholders and limited partners, including over $23 billion in digital real estate investments through Digital Colony, its digital infrastructure platform. Colony Capital, structured as a REIT, is headquartered in Los Angeles with key offices in Boca Raton, New York, and London, and has over 350 employees across 20 locations in 11 countries.

Full CLNY Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this CLNY vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLNY vs SCHDCLNY vs JEPICLNY vs OCLNY vs KOCLNY vs MAINCLNY vs HTGCCLNY vs GBDCCLNY vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.